Pharmacist and ICU doctor telehealth follow-up after ICU discharge
Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome in Survivors of Critical Illness: a Pilot Randomized Controlled Trial
This pilot will test whether pharmacist-led telehealth visits coordinated with an ICU physician help adults recovering from a critical illness improve their recovery after hospital discharge.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Sponsor | Malcom Randall VA Medical Center Federal |
| Locations | 1 site (Gainesville, Florida) |
| Trial ID | NCT06983496 on ClinicalTrials.gov |
What this trial studies
This is a pilot randomized controlled trial testing a collaborative pharmacist–intensivist telehealth follow-up program delivered about one and three months after hospital discharge. Enrolled adults who required prolonged ICU care or mechanical ventilation are randomized to receive pharmacist telehealth visits that screen for post-intensive care syndrome (PICS) and recommend interventions, or to receive usual care. The main goal is to determine whether running a larger randomized trial of this intervention is feasible and acceptable. Key eligibility includes adults discharged to home who can participate in telehealth, while patients discharged to long-term facilities or with very limited life expectancy are excluded.
Who should consider this trial
Good fit: Ideal candidates are adults (18–89) who survived a medical or surgical ICU stay with respiratory failure requiring invasive mechanical ventilation for ≥24 hours or an ICU stay ≥7 days, are being discharged home, and can use telehealth.
Not a fit: Patients who are pregnant, incarcerated, have life expectancy under six months or are discharged to skilled nursing/rehabilitation/long-term care, or who cannot do telehealth are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, this approach could catch medication issues and PICS symptoms earlier, improving recovery and potentially reducing avoidable complications or readmissions.
How similar studies have performed: Multidisciplinary post-ICU follow-up programs have shown some promise, but pharmacist-intensivist telehealth models are relatively novel and have limited prior evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults 18-89 years of age * Required admission to either medical or surgical ICU * Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days * Anticipated discharge to home after hospitalization * Consent from patients themselves or a legally authorized representative if necessary Exclusion Criteria: * Pregnancy * Incarceration/Imprisonment * Life expectancy less than 6 months or enrolled in hospice/palliative care * Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility * Unable to participate in telehealth
Where this trial is running
Gainesville, Florida
- Malcom Randall Veterans Affairs Medical Center — Gainesville, Florida, United States (Recruiting)
Study contacts
- Study coordinator: Andrew J Franck, Pharm.D.
- Email: Andrew.Franck@va.gov
- Phone: 3523761611
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.